Title : Outcome of Asunaprevir/Daclatasvir Combination Therapy for Chronic Liver Disease Type C.

Pub. Date : 2016

PMID : 27750228






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 In Japan, in September 2014, IFN-free asunaprevir (ASV) and daclatasvir (DCV) became available for combination therapy. asunaprevir interferon alpha 1 Homo sapiens
2 In Japan, in September 2014, IFN-free asunaprevir (ASV) and daclatasvir (DCV) became available for combination therapy. asunaprevir interferon alpha 1 Homo sapiens